| 期 |
栏目 |
标题 |
文件 |
| 编号 8 (2016) |
Articles |
COMBINATION OF VEMURAFENIB+KOBIMETINIB FUNDAMENTALLY CHANGES PROGNOSIS FOR METASTATIC MELANOMA |
|
| 编号 17 (2016) |
Articles |
ROLE OF NEW ANTIANGIOGENIC DRUGS IN THE SECOND-LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER |
|
| 编号 7 (2018) |
Articles |
VSTUPITEL'NOE SLOVO KURATORA |
|
| 编号 7 (2018) |
Articles |
GONADOTROPIN-RELEASING HORMONE AGONISTS-INDUCED OVARIAN SUPPRESSION IN EARLY BREAST CANCER |
|
| 编号 7 (2018) |
Articles |
SYSTEMIC THERAPY FOR ADVANCED OVARIAN CANCER IN BRCA1 MUTATION CARRIERS -NEW THERAPEUTIC APPROACHES: RESULTS OF A PROSPECTIVE NON-RANDOMIZED MULTI-CENTER STUDY |
|
| 卷 26, 编号 7 (2019) |
Articles |
Prognostic markers for testicular germ cell tumors. Research perspectives |
|
| 卷 26, 编号 7 (2019) |
Articles |
Intermediate assessment of the results of a clinical study of a neoadjuvant combined treatment of patients with high-risk and very high-risk prostate cancer |
|
| 卷 26, 编号 7 (2019) |
Articles |
Modern immunotherapy for kidney cancer |
|
| 卷 26, 编号 7 (2019) |
Articles |
PEComas: what are the treatment options? Literature review and personal experience |
|
| 卷 26, 编号 12 (2019) |
Articles |
The predictive value of nutritional deficiency in the treatment of patients with locally advanced stomach cancer |
|
| 卷 26, 编号 12 (2019) |
Articles |
A prospective non-randomized trial: the use of platinum-containing chemotherapy with mitomycin for relapses of BRCA1-associated ovarian cancer |
|
| 卷 27, 编号 7 (2020) |
Articles |
Rare immuno-mediated adverse events: literature review |
|
| 卷 27, 编号 7 (2020) |
Articles |
Prospects for the use of immunotherapy in the treatment of head and neck squamous cell carcinoma |
|
| 卷 27, 编号 7 (2020) |
Articles |
Comparison of systems for evaluating the effectiveness of modern immunotherapy |
|
| 卷 27, 编号 7 (2020) |
Articles |
Evaluation of the effectiveness and the possibility of optimizing the methodology for analyzing the plasma microRNA-371-3 (HSA-miR-371-3p) level for the diagnosis and monitoring of the effect of therapy of germ cell tumors in men |
|
| 卷 27, 编号 7 (2020) |
Articles |
Predictive and prognostic markers in the treatment of patients with solid tumors |
|
| 卷 27, 编号 7 (2020) |
Articles |
The experience of using the combined targeted regimen vemurafenib+cobimetinib in the treatment of metastatic skin melanoma with a BRAF V600E mutation in a patient with HIV infection receiving antiretroviral therapy |
|
| 卷 27, 编号 11 (2020) |
Articles |
Ten-year experience of pharmacotherapy for soft tissue sarcomas |
|
| 卷 27, 编号 11 (2020) |
Articles |
The use of panitumumab in the treatment of chemoresistant metastatic sigmoid colon adenocarcinoma: a clinical case |
|
| 卷 28, 编号 7 (2021) |
Articles |
Experience of using prolgolimab in real clinical practice |
|
| 卷 28, 编号 7 (2021) |
Articles |
Impact of nutritional deficiency and sarcopenia on the efficacy of neoadjuvant chemotherapy in patients with locally advanced gastric cancer: a retrospective study |
|
| 卷 28, 编号 7 (2021) |
Articles |
Assessment of the dynamics of immunological parameters at the beginning of therapy as prognostic and predictive factors in patients with melanoma |
|
| 卷 28, 编号 7 (2021) |
Articles |
Features of examination and systemic treatment of malignant neoplasms in gerontological patients |
|
| 卷 28, 编号 11 (2021) |
Articles |
Neoadjuvant immunotherapy for non-small cell lung cancer |
|
| 卷 29, 编号 11/12 (2022) |
Articles |
Possibilities of the combination of avelumab and axitinib in the first line in patients with advanced renal cell carcinoma |
|
